SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Xintong Zhang, Anyao Bi, Quansheng Gao, Shuai Zhang, Kunzhu Huang, Zhiguo Liu, Tang Gao, Wenbin Zeng, Advances of Molecular Imaging for Monitoring the Anatomical and Functional Architecture of the Olfactory System, ACS Chemical Neuroscience, 2016, 7, 1, 4

    CrossRef

  2. 2
    Heinz Reichmann, Modern treatment in Parkinson’s disease, a personal approach, Journal of Neural Transmission, 2016, 123, 1, 73

    CrossRef

  3. 3
    David J. Brooks, Molecular imaging of dopamine transporters, Ageing Research Reviews, 2016,

    CrossRef

  4. 4
    Giancarlo Ottaviano, Giuliana Frasson, Ennio Nardello, Alessandro Martini, Olfaction deterioration in cognitive disorders in the elderly, Aging Clinical and Experimental Research, 2016, 28, 1, 37

    CrossRef

  5. 5
    Olaf Eberhardt, Helge Topka, The preclinical stage of movement disorders, Basal Ganglia, 2016, 6, 1, 35

    CrossRef

  6. 6
    Sinem Tunc, Julia Graf, Vera Tadic, Norbert Brüggemann, Alexander Schmidt, Mohamed Al-Khaled, Simone Wolff, Eva-Juliane Vollstedt, Anne Lorwin, Jennie Hampf, Linda Piskol, Christine Klein, Johann Hagenah, Meike Kasten, A population-based study on combined markers for early Parkinson's disease, Movement Disorders, 2015, 30, 4
  7. 7
    Dolores Vilas, Lourdes Ispierto, Ramiro Álvarez, Claustre Pont-Sunyer, María José Martí, Francesc Valldeoriola, Yaroslau Compta, Oriol de Fabregues, Jorge Hernández-Vara, Víctor Puente, Matilde Calopa, Serge Jaumà, Jaume Campdelacreu, Miquel Aguilar, Pilar Quílez, Pilar Casquero, Francisco Lomeña, José Ríos, Eduardo Tolosa, Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers, Parkinsonism & Related Disorders, 2015, 21, 10, 1170

    CrossRef

  8. 8
    Andrea Pilotto, Rezzak Yilmaz, Daniela Berg, Developments in the Role of Transcranial Sonography for the Differential Diagnosis of Parkinsonism, Current Neurology and Neuroscience Reports, 2015, 15, 7

    CrossRef

  9. 9
    Olga Waln, Ying Wu, Reid Perlman, Juliet Wendt, Anh K. Van, Joseph Jankovic, Dopamine transporter imaging in essential tremor with and without parkinsonian features, Journal of Neural Transmission, 2015, 122, 11, 1515

    CrossRef

  10. 10
    Sven R Suwijn, Caroline JM van Boheemen, Rob J de Haan, Gerrit Tissingh, Jan Booij, Rob MA de Bie, The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson’s disease or clinically uncertain parkinsonism: a systematic review, EJNMMI Research, 2015, 5, 1

    CrossRef

  11. 11
    Ivanka Štenc Bradvica, Ivan Mihaljević, Silva Butković-Soldo, Dragutin Kadojić, Marina Titlić, Mario Bradvica, Kristina Kralik, Transcranial sonography and the pocket smell test in the differential diagnosis between parkinson’s disease and essential tremor, Neurological Sciences, 2015, 36, 8, 1403

    CrossRef

  12. 12
    H.C. Hopf, Therapie-Handbuch Grundwerk inkl 6. Lfg., 2015,

    CrossRef

  13. 13
    D.J. Brooks, Brain Mapping, 2015,

    CrossRef

  14. 14
    F. Brigo, A. Matinella, R. Erro, M. Tinazzi, [¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis, European Journal of Neurology, 2014, 21, 11
  15. 15
    Francisco Pan-Montojo, Heinz Reichmann, Considerations on the role of environmental toxins in idiopathic Parkinson’s disease pathophysiology, Translational Neurodegeneration, 2014, 3, 1, 10

    CrossRef

  16. 16
    Roberto González, Antonio Barrientos, Jaime del Cerro, Benito Coca, DIMETER: A Haptic Master Device for Tremor Diagnosis in Neurodegenerative Diseases, Sensors, 2014, 14, 3, 4536

    CrossRef

  17. 17
    Karlijn J. Doorn, Benjamin Drukarch, Anne-Marie van Dam, Paul J. Lucassen, Hippocampal Proliferation Is Increased in Presymptomatic Parkinson’s Disease and due to Microglia, Neural Plasticity, 2014, 2014, 1

    CrossRef

  18. 18
    Michele Tinazzi, Francesca Morgante, Angela Matinella, Tommaso Bovi, Antonino Cannas, Paolo Solla, Francesco Marrosu, Alessandra Nicoletti, Mario Zappia, Antonina Luca, Angela Di Stefano, Letterio Morgante, Claudio Pacchetti, Brigida Minafra, Massimo Sciarretta, Carlo Dallocchio, Simone Rossi, Monica Ulivelli, Roberto Ceravolo, Daniela Frosini, Andrea Cipriani, Corrado Barbui, Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study, Schizophrenia Research, 2014, 152, 2-3, 344

    CrossRef

  19. 19
    Amit Batla, Roberto Erro, Maria Stamelou, Susanne A. Schneider, Petra Schwingenschuh, Christos Ganos, Kailash P. Bhatia, Patients with scans without evidence of dopaminergic deficit: A long-term follow-up study, Movement Disorders, 2014, 29, 14
  20. 20
    A. J. Noyce, J. P. Bestwick, L. Silveira-Moriyama, C. H. Hawkes, C. H. Knowles, J. Hardy, G. Giovannoni, S. Nageshwaran, C. Osborne, A. J. Lees, A. Schrag, PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results, Journal of Neurology, Neurosurgery & Psychiatry, 2014, 85, 1, 31

    CrossRef

  21. 21
    Petra Bártová, Otakar Kraft, Jaromír Bernátek, Martin Havel, Pavel Ressner, Kateřina Langová, Roman Herzig, David Školoudík, Transcranial Sonography and 123I-FP-CIT Single Photon Emission Computed Tomography in Movement Disorders, Ultrasound in Medicine & Biology, 2014, 40, 10, 2365

    CrossRef

  22. 22
    Andre C. Felicio, A. Jon Stoessl, Imaging of the Human Brain in Health and Disease, 2014,

    CrossRef

  23. 23
    Pankaj A. Agarwal, A. Jon Stoessl, Biomarkers for trials of neuroprotection in Parkinson's disease, Movement Disorders, 2013, 28, 1
  24. 24
    Daniela Berg, Anthony E Lang, Ronald B Postuma, Walter Maetzler, Guenther Deuschl, Thomas Gasser, Andrew Siderowf, Anthony H Schapira, Wolfgang Oertel, José A Obeso, C Warren Olanow, Werner Poewe, Matthew Stern, Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities, The Lancet Neurology, 2013, 12, 5, 514

    CrossRef

  25. You have free access to this content25
    Hiroshige Fujishiro, Eizo Iseki, Shinichiro Nakamura, Koji Kasanuki, Yuhei Chiba, Kazumi Ota, Norio Murayama, Kiyoshi Sato, Dementia with Lewy bodies: early diagnostic challenges, Psychogeriatrics, 2013, 13, 2
  26. 26
    Daniela Berg, Stefanie Behnke, Klaus Seppi, Jana Godau, Stefanie Lerche, Philipp Mahlknecht, Inga Liepelt-Scarfone, Christoph Pausch, Niko Schneider, Alexandra Gaenslen, Kathrin Brockmann, Karin Srulijes, Heiko Huber, Isabel Wurster, Heike Stockner, Stefan Kiechl, Johann Willeit, Arno Gasperi, Klaus Fassbender, Thomas Gasser, Werner Poewe, Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease, Movement Disorders, 2013, 28, 2
  27. 27
    Stefanie Behnke, Dirk Hellwig, Jan Bürmann, Anne Runkel, Georgios Farmakis, Carl M. Kirsch, Klaus Fassbender, Georg Becker, Ulrich Dillmann, Jörg Spiegel, Evaluation of transcranial sonographic findings and MIBG cardiac scintigraphy in the diagnosis of idiopathic Parkinson's disease, Parkinsonism & Related Disorders, 2013, 19, 11, 995

    CrossRef

  28. 28
    B. Mollenhauer, F. Sixel-Döring, A. Storch, C. Schneider, R. Hilker, E. Kalbe, Früherkennung der Parkinson-Krankheit, Der Nervenarzt, 2013, 84, 8, 918

    CrossRef

  29. 29
    Alex Iranzo, Parkinson Disease and Sleep: Sleep–Wake Changes in the Premotor Stage of Parkinson Disease; Impaired Olfaction and Other Prodromal Features, Current Neurology and Neuroscience Reports, 2013, 13, 9

    CrossRef

  30. 30
    Antonia Maass, Heinz Reichmann, Sleep and non-motor symptoms in Parkinson’s disease, Journal of Neural Transmission, 2013, 120, 4, 565

    CrossRef

  31. 31
    Hideto Miwa, Transcranial sobography of substantia nigra in patients with Parkinson’s disease, Rinsho Shinkeigaku, 2013, 53, 11, 981

    CrossRef

  32. 32
    David J. Brooks, Handbook of Parkinson’s Disease, 2013,

    CrossRef

  33. 33
    Antoniya Todorova, Kallol Ray Chaudhuri, Parkinson’s Disease: Diagnosis, Motor Symptoms and Non-Motor Features, 2013,

    CrossRef

  34. 34
    David Brooks, Handbook of Parkinson's Disease, Fifth Edition, 2013,

    CrossRef

  35. 35
    Johann Hagenah, Norbert Brüggemann, Basal ganglia sonography: Will it mature into a preclinical diagnostic tool for Parkinson’s disease?, Basal Ganglia, 2012, 2, 4, 183

    CrossRef

  36. 36
    Johannes Thome, Ann-Christine Ehlis, Andreas J. Fallgatter, Kerstin Krauel, Klaus W. Lange, Peter Riederer, Marcel Romanos, Regina Taurines, Oliver Tucha, Marat Uzbekov, Manfred Gerlach, Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD, World Journal of Biological Psychiatry, 2012, 13, 5, 379

    CrossRef

  37. 37
    M. O. Izawa, H. Miwa, Y. Kajimoto, T. Kondo, Combination of transcranial sonography, olfactory testing, and MIBG myocardial scintigraphy as a diagnostic indicator for Parkinson’s disease, European Journal of Neurology, 2012, 19, 3
  38. 38
    Ronald B. Postuma, Dag Aarsland, Paolo Barone, David J. Burn, Christopher H. Hawkes, Wolfgang Oertel, Tjalf Ziemssen, Identifying prodromal Parkinson's disease: Pre-Motor disorders in Parkinson's disease, Movement Disorders, 2012, 27, 5
  39. 39
    Jana Godau, Anna Hussl, Praween Lolekha, A. Jon Stoessl, Klaus Seppi, Neuroimaging: Current role in detecting pre-motor Parkinson's disease, Movement Disorders, 2012, 27, 5
  40. 40
    Elmar Lobsien, Simon Schreiner, Michail Plotkin, Andreas Kupsch, Stephan J. Schreiber, Florian Doepp, No correlation of substantia nigra echogenicity and nigrostriatal degradation in Parkinson's disease, Movement Disorders, 2012, 27, 3
  41. 41
    Yoland Smith, Thomas Wichmann, Stewart A Factor, Mahlon R DeLong, Parkinson's Disease Therapeutics: New Developments and Challenges Since the Introduction of Levodopa, Neuropsychopharmacology, 2012, 37, 1, 213

    CrossRef

  42. 42
    Jörn Lötsch, Hans-Georg Kraetsch, Jörg Wendler, Thomas Hummel, Self-ratings of higher olfactory acuity contrast with reduced olfactory test results of fibromyalgia patients, International Journal of Psychophysiology, 2012, 86, 2, 182

    CrossRef

  43. 43
    Matthew B. Stern, Anthony Lang, Werner Poewe, Toward a redefinition of Parkinson's disease, Movement Disorders, 2012, 27, 1
  44. 44
    Uwe Walter, Transcranial sonography of the cerebral parenchyma: Update on clinically relevant applications, Perspectives in Medicine, 2012, 1, 1-12, 334

    CrossRef

  45. 45
    Patricio Millar Vernetti, Santiago Perez Lloret, Malco Rossi, Daniel Cerquetti, Marcelo Merello, Validation of a new scale to assess olfactory dysfunction in patients with Parkinson’s disease, Parkinsonism & Related Disorders, 2012, 18, 4, 358

    CrossRef

  46. 46
    Anthony E. Lang, A critical appraisal of the premotor symptoms of Parkinson's disease: Potential usefulness in early diagnosis and design of neuroprotective trials, Movement Disorders, 2011, 26, 5
  47. 47
    A Jon Stoessl, WR Wayne Martin, Martin J McKeown, Vesna Sossi, Advances in imaging in Parkinson's disease, The Lancet Neurology, 2011, 10, 11, 987

    CrossRef

  48. 48
    C. Moessnang, G. Frank, U. Bogdahn, J. Winkler, M. W. Greenlee, J. Klucken, Altered Activation Patterns within the Olfactory Network in Parkinson's Disease, Cerebral Cortex, 2011, 21, 6, 1246

    CrossRef

  49. 49
    Claire Henchcliffe, Richard Dodel, M. Flint Beal, Biomarkers of Parkinson's disease and Dementia with Lewy bodies, Progress in Neurobiology, 2011, 95, 4, 601

    CrossRef

  50. 50
    L. Allainmat, A. Le Borgne, G. Pina-Jomir, C. Moreau-Triby, F.-C. Djemoussi, G. Le Rouzic, J.-L. Baulieu, C. Prunier-Aesch, Caméras hybrides TEMP-TDM et semi-quantification du 123I-FPCIT : évaluation de l’apport de la TDM, Médecine Nucléaire, 2011, 35, 2, 54

    CrossRef

  51. 51
    Lama M. Chahine, Matthew B. Stern, Diagnostic markers for Parkinsonʼs disease, Current Opinion in Neurology, 2011, 24, 4, 309

    CrossRef

  52. 52
    Makoto Tanaka, Yuko Aihara, Sachie Ikeda, Yoshiaki Aihara, Neuromelanin-related contrast in the substantia nigra semiquantitatively evaluated by magnetic resonance imaging at 3T: comparison between normal aging and Parkinson disease, Rinsho Shinkeigaku, 2011, 51, 1, 14

    CrossRef

  53. 53
    Inga Liepelt, Stefanie Behnke, Katharine Schweitzer, Björn Wolf, Jana Godau, Frank Wollenweber, Ulrich Dillmann, Alexandra Gaenslen, Adriana Di Santo, Walter Maetzler, Daniela Berg, Pre-motor signs of PD are related to SN hyperechogenicity assessed by TCS in an elderly population, Neurobiology of Aging, 2011, 32, 9, 1599

    CrossRef

  54. 54
    Eduardo Tolosa, Claustre Pont-Sunyer, Progress in defining the premotor phase of Parkinson's disease, Journal of the Neurological Sciences, 2011, 310, 1-2, 4

    CrossRef

  55. 55
    I. Liepelt-Scarfone, S. Behnke, J. Godau, K. J. Schweitzer, B. Wolf, A. Gaenslen, D. Berg, Relation of risk factors and putative premotor markers for Parkinson’s disease, Journal of Neural Transmission, 2011, 118, 4, 579

    CrossRef

  56. 56
    Uwe Walter, Substantia nigra hyperechogenicity is a risk marker of Parkinson’s disease: no, Journal of Neural Transmission, 2011, 118, 4, 607

    CrossRef

  57. 57
    Norbert Brüggemann, Johann Hagenah, Kaili Stanley, Christine Klein, Cuiling Wang, Deborah Raymond, Laurie Ozelius, Susan Bressman, Rachel Saunders-Pullman, Substantia nigra hyperechogenicity with LRRK2 G2019S mutations, Movement Disorders, 2011, 26, 5
  58. 58
    Barry J. Snow, Fiona L. Rolfe, Michelle M. Lockhart, Christopher M. Frampton, John D. O'Sullivan, Victor Fung, Robin A.J. Smith, Michael P. Murphy, Kenneth M. Taylor, A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease, Movement Disorders, 2010, 25, 11
  59. 59
    Mutsumi Iijima, Mikio Osawa, Mitsuru Momose, Tatsu Kobayakawa, Sachiko Saito, Makoto Iwata, Shinichiro Uchiyama, Cardiac sympathetic degeneration correlates with olfactory function in Parkinson's disease, Movement Disorders, 2010, 25, 9
  60. 60
    Nico J. Diederich, Vannina Pieri, Géraldine Hipp, Olivier Rufra, Sara Blyth, Michel Vaillant, Discriminative power of different nonmotor signs in early Parkinson's disease. A case–control study, Movement Disorders, 2010, 25, 7
  61. 61
    Daniela Berg, Klaus Seppi, Inga Liepelt, Katherine Schweitzer, Frank Wollenweber, Björn Wolf, Ulrich Dillmann, Heike Stockner, Jana Godau, Stefan Kiechl, Alexandra Gaenslen, Johann Willeit, Adriana Di Santo, Walter Maetzler, Thomas Gasser, Werner Poewe, Stefanie Behnke, Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly, Movement Disorders, 2010, 25, 10
  62. 62
    David J. Brooks, Examining Braak's hypothesis by imaging Parkinson's disease, Movement Disorders, 2010, 25, S1
  63. 63
    David J Brooks, Imaging dopamine transporters in Parkinson’s disease, Biomarkers in Medicine, 2010, 4, 5, 651

    CrossRef

  64. 64
    T. Hummel, M. Witt, H. Reichmann, A. Welge-Luessen, A. Haehner, Immunohistochemical, volumetric, and functional neuroimaging studies in patients with idiopathic Parkinson's disease, Journal of the Neurological Sciences, 2010, 289, 1-2, 119

    CrossRef

  65. 65
    Anthony H. V. Schapira, Eduardo Tolosa, Molecular and clinical prodrome of Parkinson disease: implications for treatment, Nature Reviews Neurology, 2010, 6, 6, 309

    CrossRef

  66. 66
    Anthony C. Vernon, Clive Ballard, Michel Modo, Neuroimaging for Lewy body disease: Is the in vivo molecular imaging of α-synuclein neuropathology required and feasible?, Brain Research Reviews, 2010, 65, 1, 28

    CrossRef

  67. 67
    James F Morley, John E Duda, Olfaction as a biomarker in Parkinson’s disease, Biomarkers in Medicine, 2010, 4, 5, 661

    CrossRef

  68. 68
    J. Hagenah, G. Seidel, Parenchym-Ultraschall bei Parkinson-Syndromen, Der Nervenarzt, 2010, 81, 10, 1189

    CrossRef

  69. 69
    L. Defebvre, F. Lejeune, Pathologie extrapyramidale : apport diagnostique de l’imagerie fonctionnelle et morphologique, Médecine Nucléaire, 2010, 34, 8, 464

    CrossRef

  70. 70
    Jana Godau, Daniela Berg, Role of Transcranial Ultrasound in the Diagnosis of Movement Disorders, Neuroimaging Clinics of North America, 2010, 20, 1, 87

    CrossRef

  71. 71
    Uwe Walter, David Školoudík, Daniela Berg, Transcranial sonography findings related to non-motor features of Parkinson's disease, Journal of the Neurological Sciences, 2010, 289, 1-2, 123

    CrossRef

  72. 72
    Ludwig Niehaus, Kai Boelmans, Transcranial Sonography in Movement Disorders, 2010,

    CrossRef

  73. 73
    Patrik Brundin, Roger A. Barker, Malin Parmar, Recent Advances in Parkinson’S Disease - Translational and Clinical Research, 2010,

    CrossRef

  74. 74
    David James Brooks, MOVEMENT DISORDERS 4, 2010,

    CrossRef

  75. 75
    Eduardo Tolosa, Joan Santamaria, Carles Gaig, Yaroslau Compta, MOVEMENT DISORDERS 4, 2010,

    CrossRef

  76. 76
    Yoshinori Kajimoto, Hideto Miwa, Tomoyoshi Kondo, Transcranial Sonography in Movement Disorders, 2010,

    CrossRef

  77. 77
    Thomas Müller, Basic Aspects of Catechol-O-Methyltransferase and the Clinical Applications of its Inhibitors, 2010,

    CrossRef

  78. 78
    Stefanie Behnke, Ute Schröder, Daniela Berg, Transcranial Sonography in Movement Disorders, 2010,

    CrossRef

  79. 79
    S. Behnke, U. Schroeder, U. Dillmann, H.G. Buchholz, M. Schreckenberger, G. Fuss, W. Reith, D. Berg, C.M. Krick, Hyperechogenicity of the substantia nigra in healthy controls is related to MRI changes and to neuronal loss as determined by F-Dopa PET, NeuroImage, 2009, 47, 4, 1237

    CrossRef

  80. 80
    Mirthe M. Ponsen, Diederick Stoffers, Jos W.R. Twisk, Erik Ch. Wolters, Henk W. Berendse, Hyposmia and executive dysfunction as predictors of future Parkinson's disease: A prospective study, Movement Disorders, 2009, 24, 7
  81. 81
    Jae Seung Kim, Seung Jun Oh, Dae Hyuk Moon, Molecular Imaging in Neurodegenerative Diseases, Journal of the Korean Medical Association, 2009, 52, 2, 151

    CrossRef

  82. 82
    Antje Haehner, Thomas Hummel, Heinz Reichmann, Olfactory dysfunction as a diagnostic marker for Parkinson’s disease, Expert Review of Neurotherapeutics, 2009, 9, 12, 1773

    CrossRef

  83. 83
    Alessandro Ferraris, Tamara Ialongo, Giulio Cesare Passali, Maria Teresa Pellecchia, Livia Brusa, Marianna Laruffa, Arianna Guidubaldi, Gaetano Paludetti, Alberto Albanese, Paolo Barone, Bruno Dallapiccola, Enza Maria Valente, Anna Rita Bentivoglio, Olfactory dysfunction in Parkinsonism caused by PINK1 mutations, Movement Disorders, 2009, 24, 16
  84. 84
    Christopher H. Hawkes, Kelly Del Tredici, Heiko Braak, Parkinson's Disease, Annals of the New York Academy of Sciences, 2009, 1170, 1
  85. 85
    Vicky L. Marshall, Cornelia B. Reininger, Moritz Marquardt, Jim Patterson, Donald M. Hadley, Wolfgang H. Oertel, Hani T.S. Benamer, Paul Kemp, David Burn, Eduardo Tolosa, Jamie Kulisevsky, Luis Cunha, Durval Costa, Jan Booij, Klaus Tatsch, K. Ray Chaudhuri, Gudrun Ulm, Oliver Pogarell, Helmut Höffken, Anja Gerstner, Donald G. Grosset, Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: A 3-year European multicenter study with repeat [123I]FP-CIT SPECT, Movement Disorders, 2009, 24, 4
  86. 86
    Jacqueline Hoeppner, Lara Prudente-Morrissey, Sabine Christiane Herpertz, Reiner Benecke, Uwe Walter, Substantia nigra hyperechogenicity in depressive subjects relates to motor asymmetry and impaired word fluency, European Archives of Psychiatry and Clinical Neuroscience, 2009, 259, 2, 92

    CrossRef

  87. 87
    Uwe Walter, Transcranial brain sonography findings in Parkinson’s disease: implications for pathogenesis, early diagnosis and therapy, Expert Review of Neurotherapeutics, 2009, 9, 6, 835

    CrossRef

  88. 88
    Annemarie M. M. Vlaar, Angela Bouwmans, Werner H. Mess, Selma C. Tromp, Wim E. J. Weber, Transcranial duplex in the differential diagnosis of parkinsonian syndromes, Journal of Neurology, 2009, 256, 4, 530

    CrossRef

  89. 89
    David Školoudík, Petra Bártová, Roman Herzig, Transcranial sonography in Parkinson’s disease, Aging Health, 2009, 5, 1, 43

    CrossRef

  90. 90
    Daniela Berg, Transcranial ultrasound as a risk marker for Parkinson's disease, Movement Disorders, 2009, 24, S2
  91. 91
    Florian Doepp, Michail Plotkin, Lara Siegel, Anatol Kivi, Doreen Gruber, Elmar Lobsien, Andreas Kupsch, Stephan J. Schreiber, Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor, Movement Disorders, 2008, 23, 3
  92. 92
    Uwe Walter, Martin Kanowski, Jörn Kaufmann, Annette Grossmann, Reiner Benecke, Ludwig Niehaus, Contemporary ultrasound systems allow high-resolution transcranial imaging of small echogenic deep intracranial structures similarly as MRI: A phantom study, NeuroImage, 2008, 40, 2, 551

    CrossRef

  93. 93
    Guido Alves, Elin Bjelland Forsaa, Kenn Freddy Pedersen, Michaela Dreetz Gjerstad, Jan Petter Larsen, Epidemiology of Parkinson’s disease, Journal of Neurology, 2008, 255, S5, 18

    CrossRef

  94. 94
    Shyamal H. Mehta, John C. Morgan, Kapil D. Sethi, Neuroimaging and transcranial ultrasonography in Parkinson’s disease, Current Neurology and Neuroscience Reports, 2008, 8, 4, 297

    CrossRef

  95. 95
    Gurutz Linazasoro, Olfaction testing in PD: Risky conclusions, Movement Disorders, 2008, 23, 7
  96. 96
    Sarah M. Kranick, John E. Duda, Olfactory Dysfunction in Parkinson’s Disease, Neurosignals, 2008, 16, 1, 35

    CrossRef

  97. 97
    Christopher H. Hawkes, Parkinson's disease and aging: Same or different process?, Movement Disorders, 2008, 23, 1
  98. 98
    B. Herting, S. Bietenbeck, K. Scholz, A. Hähner, T. Hummel, H. Reichmann, Riechstörungen bei Morbus Parkinson, Der Nervenarzt, 2008, 79, 2, 175

    CrossRef

  99. 99
    Thomas Müller, Role of homocysteine in the treatment of Parkinson's disease, Expert Review of Neurotherapeutics, 2008, 8, 6, 957

    CrossRef

  100. 100
    Inga Liepelt, Angela Wendt, Katherine J. Schweitzer, Bjoern Wolf, Jana Godau, Alexandra Gaenslen, Theresa Bruessel, Daniela Berg, Substantia nigra hyperechogenicity assessed by transcranial sonography is related to neuropsychological impairment in the elderly population, Journal of Neural Transmission, 2008, 115, 7, 993

    CrossRef

  101. 101
    David J Brooks, Technology Insight: imaging neurodegeneration in Parkinson's disease, Nature Clinical Practice Neurology, 2008, 4, 5, 267

    CrossRef

  102. 102
    Christopher H. Hawkes, The prodromal phase of sporadic Parkinson's disease: Does it exist and if so how long is it?, Movement Disorders, 2008, 23, 13
  103. 103
    Daniela Berg, Jana Godau, Uwe Walter, Transcranial sonography in movement disorders, The Lancet Neurology, 2008, 7, 11, 1044

    CrossRef

  104. 104
    Petra Bartova, David Skoloudik, Michal Bar, Pavel Ressner, Petr Hlustik, Roman Herzig, Petr Kanovsky, Transcranial sonography in movement disorders, Biomedical Papers, 2008, 152, 2, 251

    CrossRef

  105. 105
    M. Mijajlović, N. Dragašević, E. Stefanova, I. Petrović, M. Svetel, V. S. Kostić, Transcranial sonography in spinocerebellar ataxia type 2, Journal of Neurology, 2008, 255, 8, 1164

    CrossRef

  106. 106
    Jorge Hernández Vara, Marta Rubiera del Fueyo, Carles Lorenzo Bosquet, Joan Castell Conesa, Carlos A. Molina Cateriano, Francisco Miquel Rodríguez, Utilidad de la sonografía del parénquima cerebral en la enfermedad de Parkinson: Estudio comparativo con 123I-FP-CIT SPECT, Medicina Clínica, 2008, 131, 8, 285

    CrossRef

  107. 107
    Tibo Gerriets, Manfred Kaps, Stroke Part III: Investigation and Management, 2008,

    CrossRef

  108. 108
    Ji Youn Kim, Won Yong Lee, Eun Joo Chung, Hun-Jong Dhong, Analysis of olfactory function and the depth of olfactory sulcus in patients with Parkinson's disease, Movement Disorders, 2007, 22, 11
  109. 109
    David J. Brooks, Assessment of Parkinson's disease with imaging, Parkinsonism & Related Disorders, 2007, 13, S268

    CrossRef

  110. 110
    G. Linazasoro, Classical Parkinson disease versus Parkinson complex – Reflections against staging and in favour of heterogeneity, European Journal of Neurology, 2007, 14, 7
  111. 111
    Daniela Berg, Disturbance of Iron Metabolism as a Contributing Factor to SN Hyperechogenicity in Parkinson’s Disease: Implications for Idiopathic and Monogenetic Forms, Neurochemical Research, 2007, 32, 10, 1646

    CrossRef

  112. 112
    Tjalf Ziemssen, Heinz Reichmann, Non-motor dysfunction in Parkinson's disease, Parkinsonism & Related Disorders, 2007, 13, 6, 323

    CrossRef

  113. You have free access to this content113
    Antje Haehner, Thomas Hummel, Cornelia Hummel, Ulrike Sommer, Susann Junghanns, Heinz Reichmann, Olfactory loss may be a first sign of idiopathic Parkinson's disease, Movement Disorders, 2007, 22, 6
  114. 114
    C. H. Hawkes, K. Del Tredici, H. Braak, Parkinson's disease: a dual-hit hypothesis, Neuropathology and Applied Neurobiology, 2007, 33, 6
  115. 115
    Clelia Pellicano, Dario Benincasa, Vincenzo Pisani, Francesca R Buttarelli, Morena Giovannelli, Francesco E Pontieri, Prodromal non-motor symptoms of Parkinson's disease, Neuropsychiatric Disease and Treatment, 2007, 3, 1, 145

    CrossRef

  116. 116
    Christoph Scherfler, Johannes Schwarz, Angelo Antonini, Donald Grosset, Francesc Valldeoriola, Kenneth Marek, Wolfgang Oertel, Eduardo Tolosa, Andrew J. Lees, Werner Poewe, Role of DAT-SPECT in the diagnostic work up of Parkinsonism, Movement Disorders, 2007, 22, 9
  117. 117
    E. Tolosa, Y. Compta, C. Gaig, The premotor phase of Parkinson's disease, Parkinsonism & Related Disorders, 2007, 13, S2

    CrossRef

  118. 118
    Uwe Walter, Stefanie Behnke, Jens Eyding, Ludwig Niehaus, Thomas Postert, Günter Seidel, Daniela Berg, Transcranial brain parenchyma sonography in movement disorders: State of the art, Ultrasound in Medicine & Biology, 2007, 33, 1, 15

    CrossRef

  119. 119
    Hideto Miwa, Masae Okawa, Yoshinori Kajimoto, Tomoyoshi Kondo, Transcranial sonography of the substantia nigra in patients with Parkinson's disease, Journal of Neurology, 2007, 254, S4, IV15

    CrossRef

  120. 120
    Daniela Berg, Ultrasound in the (premotor) diagnosis of Parkinson's disease, Parkinsonism & Related Disorders, 2007, 13, S429

    CrossRef

  121. 121
    Thomas Müller, Oxidative Stress and Neurodegenerative Disorders, 2007,

    CrossRef

  122. 122
    David J. Brooks, Parkinson's Disease and Related Disorders, Part I, 2007,

    CrossRef

  123. 123
    Gabriela Gonzalez Aleman, Florenzano Néstor, Padilla Eduardo, Bourdieu Mercedes, Guerrero Gonzalo, Calvó María, Alberio Germán, Strejilevich Sergio, de Erausquin Gabriel A., A 37-year-old woman with celiac disease, recurrent psychosis, and Parkinsonism, Movement Disorders, 2006, 21, 5
  124. 124
    G. Webster Ross, Robert D. Abbott, Helen Petrovitch, Caroline M. Tanner, Daron G. Davis, James Nelson, William R. Markesbery, John Hardman, Kamal Masaki, Lenore Launer, Lon R. White, Association of olfactory dysfunction with incidental Lewy bodies, Movement Disorders, 2006, 21, 12
  125. 125
    E Ray Dorsey, Robert G Holloway, Bernard M Ravina, Biomarkers in Parkinson’s disease, Expert Review of Neurotherapeutics, 2006, 6, 6, 823

    CrossRef

  126. 126
    Jörg Spiegel, Alexander Storch, Wolfgang H. Jost, Early diagnosis of Parkinson’s disease, Journal of Neurology, 2006, 253, S4, iv2

    CrossRef

  127. 127
    Sharon Muzerengi, Helen Lewis, Mark Edwards, Emma Kipps, Anuj Bahl, Pablo Martinez-Martin, K Ray Chaudhuri, Non-motor symptoms in Parkinson's disease: an underdiagnosed problem, Aging Health, 2006, 2, 6, 967

    CrossRef

  128. 128
    H. Reichmann, Medikamentöse Parkinson-Therapie, Der Nervenarzt, 2005, 76, 12, 1547

    CrossRef

  129. 129
    A. Mueller, N. D. Abolmaali, A. R. Hakimi, T. Gloeckler, B. Herting, H. Reichmann, T. Hummel, Olfactory bulb volumes in patients with idiopathic Parkinson’s disease   a pilot study, Journal of Neural Transmission, 2005, 112, 10, 1363

    CrossRef

  130. 130
    Christopher Hawkes, Mussadiq Shah, Why bother testing the sense of smell?, Practical Neurology, 2005, 5, 4, 224

    CrossRef

  131. 131
    John E. Duda, Matthew B. Stern, Olfactory Dysfunction,
  132. 132
    J. William Langston, The Emerging Entity of Pre-Motor Parkinson's Disease,